Amgen Inc. Stock Repurchased and Retired During Period, Shares
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Amgen Inc. stock repurchased and retired during period, shares for the quarter ending 2013-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Amgen Inc. stock repurchased and retired during period, shares for the quarter ending 2013-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Amgen Inc. stock repurchased and retired during period, shares for the quarter ending 2013-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Amgen Inc. stock repurchased and retired during period, shares for the quarter ending 2013-03-31 was 9.10M shares, a 56.67% decline year-over-year.
- Amgen Inc. stock repurchased and retired during period, shares for fiscal 2013 was 9.10M shares, a 85.39% decline from fiscal 2012.
- Amgen Inc. stock repurchased and retired during period, shares for fiscal 2012 was 62.30M shares, a 56.83% decline from fiscal 2011.
- Amgen Inc. stock repurchased and retired during period, shares for fiscal 2011 was 144.30M shares, a 116.99% increase from fiscal 2010.
- Amgen Inc. stock repurchased and retired during period, shares for fiscal 2010 was 66.50M shares, a 12.33% increase from fiscal 2009.
| Period end | Stock Repurchased and Retired During Period, Shares 3 month | Stock Repurchased and Retired During Period, Shares 12 month |
|---|---|---|
| 2013-12-31 | 0.00 shares 10-K · filed 2014-02-24 | 9.10M shares 10-K · filed 2014-02-24 |
| 2013-09-30 | 0.00 shares 10-K · filed 2014-02-24 | 23.30M shares derived: sum of 4 quarters · filed 2014-02-24 |
| 2013-06-30 | 0.00 shares 10-K · filed 2014-02-24 | 33.00M shares derived: sum of 4 quarters · filed 2014-02-24 |
| 2013-03-31 | 9.10M shares 10-K · filed 2014-02-24 | 50.40M shares derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-12-31 | 14.20M shares 10-K · filed 2014-02-24 | 62.30M shares 10-K · filed 2014-02-24 |
| 2012-09-30 | 9.70M shares 10-K · filed 2014-02-24 | 134.10M shares derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | 17.40M shares 10-K · filed 2014-02-24 | 169.80M shares derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | 21.00M shares 10-K · filed 2014-02-24 | 165.30M shares derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | 86.00M shares 10-K · filed 2014-02-24 | 144.30M shares 10-K · filed 2014-02-24 |
| 2011-09-30 | 45.40M shares 10-K · filed 2014-02-24 | 78.80M shares derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-06-30 | 12.90M shares 10-K · filed 2014-02-24 | 40.00M shares derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-03-31 | 0.00 shares 10-K · filed 2014-02-24 | 37.40M shares derived: sum of 4 quarters · filed 2014-02-24 |
| 2010-12-31 | 20.50M shares 10-K · filed 2013-02-27 | 66.50M shares 10-K · filed 2013-02-27 |
| 2010-09-30 | 6.60M shares 10-K · filed 2013-02-27 | 67.70M shares derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-06-30 | 10.30M shares 10-K · filed 2013-02-27 | 61.10M shares derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-03-31 | 29.10M shares 10-K · filed 2013-02-27 | 50.80M shares derived: sum of 4 quarters · filed 2013-02-27 |
| 2009-12-31 | 21.70M shares 10-K · filed 2012-02-29 | 59.20M shares 10-K · filed 2012-02-29 |
| 2009-09-30 | 0.00 shares 10-K · filed 2012-02-29 | |
| 2009-06-30 | 0.00 shares 10-K · filed 2012-02-29 | |
| 2009-03-31 | 37.50M shares 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |